SEQURNA AB
Develops thermostable RNase inhibitors for advanced RNA sequencing workflows.
Oversikt
- 1–4
- Ansatte
- 2.5–5mill SEK
- Omsetning
- 2022
- Grunnlagt
Nøkkelbeslutningstakere
Antonio Lentini
Lead Computational Research & Development Specialist, and Co-founder
Joyce Noble
Lead Research & Development Specialist and Co-founder
Fredrik Olsson
Chairman of the Board
Björn Reinius
CEO and Co-founder
+4 flere kontakter i Funnelfeedr
Beskrivelse
SEQURNA is a biotechnology company specializing in innovative reagents for molecular biology research. Their flagship product is the SEQURNA® Thermostable RNase Inhibitor, designed to revolutionize RNA-sequencing workflows. Unlike traditional protein-based inhibitors, this synthetic compound maintai...